Literature DB >> 34224265

In ANCA-associated vasculitis, avacopan was superior to prednisone taper for sustained remission.

Mubeen M Khan1, Donald A Molony1.   

Abstract

SOURCE CITATION: Jayne DRW, Merkel PA, Schall TJ, et al. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021;384:599-609. 33596356.

Entities:  

Year:  2021        PMID: 34224265     DOI: 10.7326/ACPJ202107200-079

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  1 in total

1.  Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option.

Authors:  Charlotte Gabilan; Pierre Pfirmann; David Ribes; Claire Rigothier; Dominique Chauveau; Audrey Casemayou; Antoine Huart; Joost Schanstra; Magali Colombat; Stanislas Faguer; Julie Belliere
Journal:  Kidney Int Rep       Date:  2022-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.